Baseline Cytokine Profile Identifies a Favorable Outcome in a Subgroup of Colorectal Cancer Patients Treated with Regorafenib.

MLA

Abbona, Andrea, et al. “Baseline Cytokine Profile Identifies a Favorable Outcome in a Subgroup of Colorectal Cancer Patients Treated with Regorafenib.” Vaccines, vol. 11, no. 2, Feb. 2023, p. 335. EBSCOhost, https://doi.org/10.3390/vaccines11020335.

APA

Abbona, A., Ricci, V., Paccagnella, M., Granetto, C., Ruatta, F., Cauchi, C., Galizia, D., Ghidini, M., Denaro, N., Merlano, M. C., & Garrone, O. (2023). Baseline Cytokine Profile Identifies a Favorable Outcome in a Subgroup of Colorectal Cancer Patients Treated with Regorafenib. Vaccines, 11(2), 335. https://doi.org/10.3390/vaccines11020335

Chicago

Abbona, Andrea, Vincenzo Ricci, Matteo Paccagnella, Cristina Granetto, Fiorella Ruatta, Carolina Cauchi, Danilo Galizia, et al. 2023. “Baseline Cytokine Profile Identifies a Favorable Outcome in a Subgroup of Colorectal Cancer Patients Treated with Regorafenib.” Vaccines 11 (2): 335. doi:10.3390/vaccines11020335.